Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Tiotropium add-on therapy improves lung function in children with symptomatic moderate asthma.
J Allergy Clin Immunol Pract. 2018 Nov-Dec;6(6):2160-2162.e9. doi: 10.1016/j.jaip.2018.04.032. Epub 2018 May 8.
J Allergy Clin Immunol Pract. 2018.
PMID: 29751157
Free article.
Clinical Trial.
No abstract available.
A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma.
Szefler SJ, Murphy K, Harper T 3rd, Boner A, Laki I, Engel M, El Azzi G, Moroni-Zentgraf P, Finnigan H, Hamelmann E.
Szefler SJ, et al. Among authors: el azzi g.
J Allergy Clin Immunol. 2017 Nov;140(5):1277-1287. doi: 10.1016/j.jaci.2017.01.014. Epub 2017 Feb 9.
J Allergy Clin Immunol. 2017.
PMID: 28189771
Free article.
Clinical Trial.
Item in Clipboard
Tiotropium add-on therapy is safe and reduces seasonal worsening in paediatric asthma patients.
Vogelberg C, Szefler SJ, Vrijlandt EJLE, Boner AL, Engel M, El Azzi G, Vulcu SD, Moroni-Zentgraf PM, Eickmeier O, Hamelmann EH.
Vogelberg C, et al. Among authors: el azzi g.
Eur Respir J. 2019 Jun 13;53(6):1801824. doi: 10.1183/13993003.01824-2018. Print 2019 Jun.
Eur Respir J. 2019.
PMID: 31097514
Free PMC article.
Clinical Trial.
Item in Clipboard
Safety of tiotropium Respimat® in black or African-American patients with symptomatic asthma.
Graham LM, Kerstjens HAM, Vogelberg C, Hamelmann E, Szefler SJ, Pisternick-Ruf W, Engel M, El Azzi G, Unseld A, Foggs MB.
Graham LM, et al. Among authors: el azzi g.
Respir Med. 2019 Aug;155:58-60. doi: 10.1016/j.rmed.2019.07.002. Epub 2019 Jul 2.
Respir Med. 2019.
PMID: 31302579
Free article.
Clinical Trial.
Item in Clipboard
Safety and efficacy of tiotropium in children aged 1-5 years with persistent asthmatic symptoms: a randomised, double-blind, placebo-controlled trial.
Vrijlandt EJLE, El Azzi G, Vandewalker M, Rupp N, Harper T, Graham L, Szefler SJ, Moroni-Zentgraf P, Sharma A, Vulcu SD, Sigmund R, Chawes B, Engel M, Bisgaard H.
Vrijlandt EJLE, et al. Among authors: el azzi g.
Lancet Respir Med. 2018 Feb;6(2):127-137. doi: 10.1016/S2213-2600(18)30012-2. Epub 2018 Jan 18.
Lancet Respir Med. 2018.
PMID: 29361462
Clinical Trial.
Item in Clipboard
In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1-5-year-old children with persistent asthmatic symptoms.
Wachtel H, Nagel M, Engel M, El Azzi G, Sharma A, Suggett J.
Wachtel H, et al. Among authors: el azzi g.
Respir Med. 2018 Apr;137:181-190. doi: 10.1016/j.rmed.2018.03.010. Epub 2018 Mar 7.
Respir Med. 2018.
PMID: 29605203
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite